About this trial
The natural course for meningioma suggests that a majority will grow over time. Treatment is usually indicated in growing or symptomatic meningiomas. Surgery is usually primary treatment, but there is a significant risk of adverse effects. Stereotactic radiotherapy is most often reserved to treat relapses after surgery, and except for surgery and radiotherapy there are no other established treatment methods. Endovascular embolization may be used in selected cases as a preoperative adjunct to reduce intraoperative bleeding. There is a need for more treatment options in patients with meningioma, both in uncomplicated, asymptomatic cases and in more complex cases. The aim of this study is to assess radiological and clinical results of therapeutic endovascular embolization for meningioma
Eligibility criteria
Qualifiers
Radiological diagnose of typical intracranial meningioma (homogenous contrast enhancement or dural attachment)
Indication for treatment due to growth, symptoms or both
Tumor location suggestive of vascular supply via middle meningeal artery branches
Age 18 years or older
Disqualifiers
Informed consent not possible (e.g. language barriers, aphasia, cognitive impaired)
Previously treated for meningioma
Intraosseous growth
Tumor related brain edema
Trial design
Treatments tested in this trial
- Endovascular embolization